Newslist

Study just out in Nature: Vogel lab publishes new RNA technology for phages.

Team from IMIB, HIRI and RVZ way ahead with 240 kilometers per capita

Researchers at HIRI and the Chair of Microbiology at the University of Würzburg have established the connection between cell shape and function of the intestinal inhabitant Bacteroides thetaiotaomicron.

The University of Würzburg has secured funding for two Clusters of Excellence under the Excellence Strategy. One of them is the new NUCLEATE Cluster, which focuses on the innovative field of nucleic acids.

The German National Academy of Sciences Leopoldina has admitted Cynthia Sharma, an infection biologist at the University of Würzburg, to the section ‘Microbiology and Immunology’.

Nearly 80 doctoral students from the HZI (Helmholtz Centre for Infection Research Braunschweig) and the IMIB gathered on October 17 and 18 at the Medical Campus.

The ASOBIOTICS 2024 symposium provided participants with a platform to discuss the challenges of progressing antibacterial ASOs from basic research to clinical application.

The competition for the multi-million euro federal and state funding programme is entering its final phase. JMU has submitted two proposals and the results of the evaluation will be available in May 2025.

Scientists from IMIB, RVZ and HIRI exhibit their creative works

Team from the IMIB, RVZ, and HIRI collected 6,747 kilometers in three weeks

The international event, co-organized by Jörg Vogel (IMIB/HIRI), presented techniques for characterizing and modifying the complex human microbiome.

The research groups led by Cynthia Sharma, Jörg Vogel and Franziska Faber are actively involved in this Bavarian research network with innovative projects.

One step further: One JMU research project on nucleic acid research and technologies has qualified for the next round in the competition for the prestigious research grant.

Linda Popella (IMIB) and Valentina Cosi (HIRI), both from Jörg Vogel's research group, were recognized for their outstanding poster presentations at the annual meeting of the Oligonucleotide Therapeutics Society in Barcelona.

We congratulate Johannes Kullmann, who won the Best Poster Prize at Microbes and RNA 2023, an award sponsored by the journal 'microLife'.